Spring Point Project
Nonprofit profile at a glance
- EIN
- 201896813
- IRS 990 coverage
- 2010–2025
- Forms available
- Form 990 2025
- Location
- Minneapolis, MN, USA
- Phone
- 6123334108
- Rating
- 73
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Specifically Named Diseases Research
Reported finances
- Revenue
- $3,706,775
- Expenses
- $3,249,439
- Assets
- $8,268,932
- Liabilities
- $432,132
Source: IRS Form 990. Selected filing: tax year 2023. Amounts in USD.
Leadership & pay
10 people listed
Executive titles in this filing
- THOMAS SPIZZO (EXECUTIVE DIRECTOR)
Highest reported compensation
- THOMAS SPIZZO (EXECUTIVE DIRECTOR): $231,544 total reported compensation
- GERALDINE HULLUM (DIRECTOR OF ADMINISTRATION): $115,396 total reported compensation
- MEGAN MALZ (DIRECTOR OF QUALITY): $113,067 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2023. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To be the preeminent source of medical-grade porcine clinically tissue utilized to cure diseases, with the primary commitment to diabetes.
What it reported doing in 2023
Bred and raised designated pathogen-free (dpf) medical-grade pigs for use in biomedical research to treat and potentially cure type 1 diabetes. Pancreas procurement, islet isolation and encapsulation activities are underway to enable investigational new drug application (ind) preparation, which is necessary for clinical studies. The long-term program objective is to produce a sufficient supply of suitable donor pigs to serve as islet donors for diabetic patients, ultimately leading to a cure for diabetes.to date, produced over three thousand dpf pigs and manufactured and isolated over 173 million porcine islets from designated pathogen-free (dpf) animals produced at the organization's facility to support (1) preclinical transplantation studies and phase i/ii clinical preparation activities and (2) the validation of the cgmp manufacturing of a clinically suitable product in the on-site cellular manufacturing facility. Procured porcine pancreases from dpf piglets and provided to researchers for studies to develop a novel product for the treatment of type 1 diabetes and other diseases.
Operating model
- Revenue model
- Earned-program. 91% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and most voting board members are independent. The filing reports few safeguards for money sent abroad and the filing does not identify recipients for some grant dollars.
Rating breakdown
- Financial Efficiency: 75
- Transparency & Controls: 50
- Accountability: 100
- Sustainability: 63
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 78.8%; rating input score 79
- Program expense ratio: 91.7%; rating input score 92
- Fundraising efficiency: $0.28 raised per $1 spent on fundraising; rating input score 1; 1st percentile among comparable filings
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
- Pay-setting controls: 3 of 6 controls in place; rating input score 50
- Compensation committee: Pass
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Pass
- Compensation survey or study: Missing
- Board or committee approval: Pass
- Foreign activity oversight: Scored; rating input score 0
- Grant itemization coverage: Scored; rating input score 0
- Major donor itemization: Limited
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
- Governance controls: 8 of 8 controls in place; rating input score 100
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: 12.3%; rating input score 68; 68th percentile among comparable filings
- Total-asset coverage ratio: 2.54; rating input score 70; 70th percentile among comparable filings
- Liabilities to assets ratio: 0.05; rating input score 71; 71st percentile among comparable filings
- Officer compensation ratio: 14.2%; rating input score 19; 19th percentile among comparable filings
Growth
- Program expense growth: 9.8% per year; rating input score 100; 64th percentile among comparable filings
- Revenue growth: 7% per year; rating input score 100; 56th percentile among comparable filings
- Asset growth: 0.5% per year; rating input score 100; 15th percentile among comparable filings
Details
- Where the money goes: 78.8% of revenue deployed · 91.7% of spending went to programs
- Governance: 7 of 7 board members independent · 8 of 8 filing controls reported
- Programs: 1 filed program accomplishment · $3M in reported program spending
- Leadership: top reported pay $232K · 10 people listed · 3 of 6 pay-setting controls reported
- Consistency: 32 of 32 current checks pass
- Schedules: 5 filed schedules · includes foreign activity and executive pay
- Filing history: 16 filing years from 2010 to 2025
- Contacts: How to reach this organization
- Money network: 3 filed money-flow records
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Foreign activity oversight scored 0/100.
- High — Transparency & Controls: Grant itemization coverage scored 0/100.
- High — Financial Efficiency: Fundraising efficiency scored 1/100.
- High — Sustainability: Officer compensation ratio scored 19/100.